POM-V
Prescription Required
Companion Animal
Eradia 125 mg/ml Oral Suspension for Dogs
Active ingredient: Metronidazole
Form
Liquid
Species
Dogs
Manufacturer
VIRBAC
VMD MA No.
05653/5044
What it's used for
Treatment of infections of the gastrointestinal tract caused by Giardia spp. and Clostridium spp. (i.e. C. perfringens or C. difficile). Treatment of infec...
Full indications, dosage and side effects ↓The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.
Paying less for Metronidazole
-
1
Ask your vet for a written prescription
They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
-
2
Fill it at a registered online retailer
The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.
Done — we'll email you when prices land.
Prescription required
Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.
Clinical information
Eradia 125 mg/ml Oral Suspension for Dogs — SPC Details
Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.
Treatment of infections of the gastrointestinal tract caused by Giardia spp. and
Clostridium spp. (i.e. C. perfringens or C. difficile).
Treatment of infections of the urogenital tract, oral cavity, throat and skin caused by
obligate anaerobic bacteria (e.g. Clostridium spp.) susceptible to metronidazole.
Clostridium spp. (i.e. C. perfringens or C. difficile).
Treatment of infections of the urogenital tract, oral cavity, throat and skin caused by
obligate anaerobic bacteria (e.g. Clostridium spp.) susceptible to metronidazole.
Oral use.
The recommended dose is 50 mg metronidazole per kg bodyweight per day (i.e. 0.4
mL per kg bodyweight), preferably given in two equally divided doses (i.e. 25 mg
equivalent to 0.2 mL per kg bodyweight twice daily) for 5-7 days.
To ensure a correct dosage body weight should be determined as accurately as
possible to avoid underdosing and overdosing.
The following table is intended as a guide to dispensing the product at the volume
corresponding to either 25 mg/kg for administration twice daily or 50 mg/kg for
administration once daily.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Examples of
bodyweight (kg)
Volume to administer twice
daily for 25mg/kg
Volume to administer once
daily for 50mg/kg
10.4mL20.4mL0.8mL30.6mL1.2mL40.8mL1.6mL51.0mL2.0mL102.0mL4.0mL153.0mL6.0mL204.0mL8.0mL255.0mL10.0mL306.0mL12.0mL357.0mL14.0mL408.0mL16.0mL
For doses requiring more than two filled syringes, the dosing should be twice daily in
order to minimize counting and dosing errors.
The oral suspension is delivered through the package described below:
[Snap cap packaging]
A - Shake the bottle vigorously before use.
B - Unscrew the protective overcap.
C - Insert the syringe into the upper white part of the cap (finger-grip) by pushing
firmly, then, while pushing, turn the syringe to the right (clockwise) until the green
smile appears.
D - Turn the bottle upside down and withdraw the prescribed volume of the product,
in the upside down position.
E - Once the correct volume of the product has been drawn into the syringe, unscrew
the syringe from the cap without pushing by turning it to the left (counterclockwise)
until the red smile appears again, then continue to turn in order to unfasten the
syringe.
The system can also be closed by turning the finger-grip manually.
F - Screw the protective overcap back on.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
[Screw cap packaging]
A-Shake vigorously the bottle before use.
B-Push down strongly and turn right the colored part of the cap until it is locked.
C-Open the hindge flap.
D-Plug the syringe on the bottle in upright position.
E-Turn over the bottle and sample the prescribed volume of the product in upside
down position.
F-Once filled, turn over the bottle. Unplug the syringe in upright position.
G-Close the hindge flap.
H-Turn left and pull up the colored part of the cap.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
The recommended dose is 50 mg metronidazole per kg bodyweight per day (i.e. 0.4
mL per kg bodyweight), preferably given in two equally divided doses (i.e. 25 mg
equivalent to 0.2 mL per kg bodyweight twice daily) for 5-7 days.
To ensure a correct dosage body weight should be determined as accurately as
possible to avoid underdosing and overdosing.
The following table is intended as a guide to dispensing the product at the volume
corresponding to either 25 mg/kg for administration twice daily or 50 mg/kg for
administration once daily.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Examples of
bodyweight (kg)
Volume to administer twice
daily for 25mg/kg
Volume to administer once
daily for 50mg/kg
10.4mL20.4mL0.8mL30.6mL1.2mL40.8mL1.6mL51.0mL2.0mL102.0mL4.0mL153.0mL6.0mL204.0mL8.0mL255.0mL10.0mL306.0mL12.0mL357.0mL14.0mL408.0mL16.0mL
For doses requiring more than two filled syringes, the dosing should be twice daily in
order to minimize counting and dosing errors.
The oral suspension is delivered through the package described below:
[Snap cap packaging]
A - Shake the bottle vigorously before use.
B - Unscrew the protective overcap.
C - Insert the syringe into the upper white part of the cap (finger-grip) by pushing
firmly, then, while pushing, turn the syringe to the right (clockwise) until the green
smile appears.
D - Turn the bottle upside down and withdraw the prescribed volume of the product,
in the upside down position.
E - Once the correct volume of the product has been drawn into the syringe, unscrew
the syringe from the cap without pushing by turning it to the left (counterclockwise)
until the red smile appears again, then continue to turn in order to unfasten the
syringe.
The system can also be closed by turning the finger-grip manually.
F - Screw the protective overcap back on.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
[Screw cap packaging]
A-Shake vigorously the bottle before use.
B-Push down strongly and turn right the colored part of the cap until it is locked.
C-Open the hindge flap.
D-Plug the syringe on the bottle in upright position.
E-Turn over the bottle and sample the prescribed volume of the product in upside
down position.
F-Once filled, turn over the bottle. Unplug the syringe in upright position.
G-Close the hindge flap.
H-Turn left and pull up the colored part of the cap.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Do not use in case of hepatic disorders.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
Do not use in case of hypersensitivity to the active substance or to any of the
excipients.
The following adverse reactions may occur after administration of metronidazole:
vomiting, hepatotoxicity and neutropenia.
In very rare cases, neurological signs may occur especially after prolonged treatment
with metronidazole.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
vomiting, hepatotoxicity and neutropenia.
In very rare cases, neurological signs may occur especially after prolonged treatment
with metronidazole.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
None.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Special precautions for use in animals
Due to the likely variability (time, geographical) in the occurrence of metronidazole
resistant bacteria, bacteriological sampling and susceptibility testing are
recommended.
Whenever possible, the product should only be used based on susceptibility testing.
Official, national and regional antimicrobial policies should be taken into account
when the veterinary medicinal product is used.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Metronidazole has confirmed mutagenic and genotoxic properties in laboratory
animals as well as in humans. Metronidazole is a confirmed carcinogen in laboratory
animals and thus may have carcinogenic effects in humans as well. However, there
is inadequate evidence in humans for the carcinogenicity of metronidazole.
The product can cause skin sensitisation. In case of known hypersensitivity to
metronidazole or other nitroimidazole derivatives or one of the components of the
product, avoid contact with the veterinary medicinal product.
Avoid contact with the skin or mucous membranes including hand-to-mouth contact.
To avoid such contact wear impervious gloves when handling the product and/or for
direct administration into the animal's mouth.
Do not allow treated dogs to lick persons immediately after intake of the medication.
Wash hands after use.
In case of skin contact, wash thoroughly the affected area.
Metronidazole may cause adverse (neurological) effects.
Avoid accidental ingestion.
Do not drink, eat or smoke when administering the product.
Close the bottle immediately after use to avoid the child gaining access to the
contents. Do not leave a syringe containing solution in the sight or reach of children.
In order to prevent children from getting access to used syringes, keep the syringes
in the original packaging after use.
In case of accidental ingestion, seek-medical advice immediately and show the
package leaflet or the label to physician.
Additional warnings when administering the product into the feed:
Avoid the access of children to the dog’s medicated food. In order to prevent children
from getting access to the dog’s medicated food, pour it over a part of the feed and
wait until the animal has completely consumed the medicated feed, then administer
the rest of the feed. Give the treatment out of the sight and reach of children. Any
uneaten medicated food must be removed immediately and the bowl washed
thoroughly; wear gloves and wash hands when handling the product and cleaning the
contaminated food bowl.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Special precautions for use in animals
Due to the likely variability (time, geographical) in the occurrence of metronidazole
resistant bacteria, bacteriological sampling and susceptibility testing are
recommended.
Whenever possible, the product should only be used based on susceptibility testing.
Official, national and regional antimicrobial policies should be taken into account
when the veterinary medicinal product is used.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Metronidazole has confirmed mutagenic and genotoxic properties in laboratory
animals as well as in humans. Metronidazole is a confirmed carcinogen in laboratory
animals and thus may have carcinogenic effects in humans as well. However, there
is inadequate evidence in humans for the carcinogenicity of metronidazole.
The product can cause skin sensitisation. In case of known hypersensitivity to
metronidazole or other nitroimidazole derivatives or one of the components of the
product, avoid contact with the veterinary medicinal product.
Avoid contact with the skin or mucous membranes including hand-to-mouth contact.
To avoid such contact wear impervious gloves when handling the product and/or for
direct administration into the animal's mouth.
Do not allow treated dogs to lick persons immediately after intake of the medication.
Wash hands after use.
In case of skin contact, wash thoroughly the affected area.
Metronidazole may cause adverse (neurological) effects.
Avoid accidental ingestion.
Do not drink, eat or smoke when administering the product.
Close the bottle immediately after use to avoid the child gaining access to the
contents. Do not leave a syringe containing solution in the sight or reach of children.
In order to prevent children from getting access to used syringes, keep the syringes
in the original packaging after use.
In case of accidental ingestion, seek-medical advice immediately and show the
package leaflet or the label to physician.
Additional warnings when administering the product into the feed:
Avoid the access of children to the dog’s medicated food. In order to prevent children
from getting access to the dog’s medicated food, pour it over a part of the feed and
wait until the animal has completely consumed the medicated feed, then administer
the rest of the feed. Give the treatment out of the sight and reach of children. Any
uneaten medicated food must be removed immediately and the bowl washed
thoroughly; wear gloves and wash hands when handling the product and cleaning the
contaminated food bowl.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
Metronidazole may have an inhibitory effect on the degradation of other drugs in the
liver, such as phenytoin, cyclosporine and warfarin.
Cimetidine may decrease the hepatic metabolism of metronidazole resulting in
increased serum concentration of metronidazole.
Phenobarbital may increase hepatic metabolism of metronidazole resulting in
decreased serum concentration of metronidazole.
liver, such as phenytoin, cyclosporine and warfarin.
Cimetidine may decrease the hepatic metabolism of metronidazole resulting in
increased serum concentration of metronidazole.
Phenobarbital may increase hepatic metabolism of metronidazole resulting in
decreased serum concentration of metronidazole.
Store below 30° C.
For doses requiring more than two filled syringes, the dosing should be twice daily in
order to minimize counting and dosing errors.
The oral suspension is delivered through the package described below:
[Snap cap packaging]
A - Shake the bottle vigorously before use.
B - Unscrew the protective overcap.
C - Insert the syringe into the upper white part of the cap (finger-grip) by pushing
firmly, then, while pushing, turn the syringe to the right (clockwise) until the green
smile appears.
D - Turn the bottle upside down and withdraw the prescribed volume of the product,
in the upside down position.
E - Once the correct volume of the product has been drawn into the syringe, unscrew
the syringe from the cap without pushing by turning it to the left (counterclockwise)
until the red smile appears again, then continue to turn in order to unfasten the
syringe.
The system can also be closed by turning the finger-grip manually.
F - Screw the protective overcap back on.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
[Screw cap packaging]
A-Shake vigorously the bottle before use.
B-Push down strongly and turn right the colored part of the cap until it is locked.
C-Open the hindge flap.
D-Plug the syringe on the bottle in upright position.
E-Turn over the bottle and sample the prescribed volume of the product in upside
down position.
F-Once filled, turn over the bottle. Unplug the syringe in upright position.
G-Close the hindge flap.
H-Turn left and pull up the colored part of the cap.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Adverse events are more likely to occur at doses and treatment durations in excess
of the recommended treatment regimen. If neurological signs occur, treatment should
be discontinued and the patient should be treated symptomatically.
4.11 Withdrawal period(s)
Not applicable.
5.
order to minimize counting and dosing errors.
The oral suspension is delivered through the package described below:
[Snap cap packaging]
A - Shake the bottle vigorously before use.
B - Unscrew the protective overcap.
C - Insert the syringe into the upper white part of the cap (finger-grip) by pushing
firmly, then, while pushing, turn the syringe to the right (clockwise) until the green
smile appears.
D - Turn the bottle upside down and withdraw the prescribed volume of the product,
in the upside down position.
E - Once the correct volume of the product has been drawn into the syringe, unscrew
the syringe from the cap without pushing by turning it to the left (counterclockwise)
until the red smile appears again, then continue to turn in order to unfasten the
syringe.
The system can also be closed by turning the finger-grip manually.
F - Screw the protective overcap back on.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
[Screw cap packaging]
A-Shake vigorously the bottle before use.
B-Push down strongly and turn right the colored part of the cap until it is locked.
C-Open the hindge flap.
D-Plug the syringe on the bottle in upright position.
E-Turn over the bottle and sample the prescribed volume of the product in upside
down position.
F-Once filled, turn over the bottle. Unplug the syringe in upright position.
G-Close the hindge flap.
H-Turn left and pull up the colored part of the cap.
Administer the product by pouring it over a part of the feed or by direct administration
into the animal's mouth. Wear impervious gloves when handling the product and/or
administering the product into the animal's mouth.
When administered over the feed, wait until the animal has completely consumed the
medicated feed, then administer the rest of the feed.
Revised: April 2024
Divergence from NI MA following AN:03958/2022
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Adverse events are more likely to occur at doses and treatment durations in excess
of the recommended treatment regimen. If neurological signs occur, treatment should
be discontinued and the patient should be treated symptomatically.
4.11 Withdrawal period(s)
Not applicable.
5.
This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.
Medication costs adding up?
Pet insurance can cover prescription medications. Find the right policy for your pet.
Same active ingredient
Other Products Containing Metronidazole
These products share the same active ingredient and may be suitable alternatives. Always consult your vet.
Eradia 125 mg/ml Oral Suspension for Dogs
POM-VVirbac
liquid
Dogs
Metrobactin 250 mg Tablets for Dogs and Cats
POM-VDechra Regulatory B.V.
tablet
Cats
Dogs
Metrobactin 500 mg Tablets for Dogs and Cats
POM-VDechra Regulatory B.V.
tablet
Cats
Dogs
Metrocare Flavour 250 mg Tablets for Dogs and Cats
POM-VEcuphar NV
tablet
Cats
Dogs
Metrocare Flavour 500 mg Tablets for Dogs and Cats
POM-VEcuphar NV
tablet
Cats
Dogs
Metrotab Vet. Flavoured 1000 mg Tablets for Dogs
POM-VCP Pharma Handelsgesellschaft mbH
tablet
Cats
Dogs
Alternative options to consider
Retailers we earn a commission from. It costs you nothing and never changes what we show.
The Pharm Pet Co.
The Pharm Pet Co. — Pet Pharmacy
UK online pet pharmacy. Flea, worm, prescription medications, supplements and pet food. Save vs vet prices.
Save up to 50%
Shop now
Pharmacy2U
Pet Care at Pharmacy2U
The UK's largest online pharmacy. Pet wormers, flea treatments, dental and joint care. Free delivery on orders over £30.
Free delivery £30+
Shop now
VetBox
VetBox Flea & Worm Protection for Dogs
Vet-founded monthly parasite subscription. Flea, tick and worm protection delivered to your door. Founded by Dr Will Woodley, protecting 30,000+ pets.
From £9.99/month
Shop now
We may earn a small commission if you purchase through these links, at no extra cost to you.
Also in antibiotic
Related Medications
Actionis 50 mg/ml, Suspension for Injection for Pigs and Cattle
POM-VCeftiofur
injection
Rx
Cattle
Pigs
Actionis 50 mg/ml, Suspension for Injection for Pigs and Cattle
POM-VCeftiofur
injection
Rx
Cattle
Pigs
Adaxio Shampoo for Dogs
POM-VChlorhexidine Gluconate + Miconazole Nitrate
shampoo
Rx
Dogs
Adaxio Shampoo for Dogs
POM-VChlorhexidine Gluconate + Miconazole Nitrate
shampoo
Rx
Dogs
Advocin 180, 180 mg/ml, Solution for Injection for Cattle
POM-VDanofloxacin
injection
Rx
Cattle
Aivlosin 42.5 mg/g Oral Powder for Pigs
POM-VTylvalosin
powder
Rx
Pigs
Find cheaper vets near you
Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.